Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study

References

• Soler-CataluñaJJ, Martinez-GarciaMA, Román SánchezP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• MüllerovaH, MaselliDJ, LocantoreN, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147:999–1007. doi:10.1378/chest.14-065525356881
   PubMed Web of Science ®Google Scholar
• ManteroM, RoglianiP, Di PasqualeM, et al. Acute exacerbations of COPD: risk factors for failure and relapse. Int J Chron Obstruct Pulmon Dis. 2017;12:2687–2693. doi:10.2147/COPD.S14525328932112
   PubMed Web of Science ®Google Scholar
• CouillardS, LarivéeP, CourteauJ, et al. Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 2017;151:366–373. doi:10.1016/j.chest.2016.10.00327746201
   PubMed Web of Science ®Google Scholar
• LandboC, PrescottE, LangeP, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856–1861. doi:10.1164/ajrccm.160.6.990211510588597
   PubMed Web of Science ®Google Scholar
• ChailleuxE, LaabanJP, VealeD. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2003;123:1460–1466. doi:10.1378/chest.123.5.146012740261
   PubMed Web of Science ®Google Scholar
• ZapateroA, BarbaR, RuizJ, et al. Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet. 2013;1:16–22. doi:10.1111/jhn.12088
   Web of Science ®Google Scholar
• GenaoL, DurheimMT, MiX, et al. Early and long-term outcomes of older adults after acute care encounters for chronic obstructive pulmonary disease exacerbation. Ann Am Thorac Soc. 2015;12:1805–1812. doi:10.1513/AnnalsATS.201504-250OC26394180
   PubMed Web of Science ®Google Scholar
• HallinR, Koivisto-HurstiUK, LindbergE, et al. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2006;100:561–567. doi:10.1016/j.rmed.2005.05.02016019198
   PubMed Web of Science ®Google Scholar
• ZhuM, WangT, WangC, et al. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2597–2607. doi:10.2147/COPD.S10138227799758
   PubMed Web of Science ®Google Scholar
• SethiS. New Developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis. 2004;17:113. doi:10.1097/00001432-200404000-0000815021050
   PubMed Web of Science ®Google Scholar
• LiF, YuanMZ, WangL, et al. Characteristics and prognosis of pulmonary infection in patients with neurologic disease and hypoalbuminemia. Expert Rev Anti Infect Ther. 2015;13:521–526. doi:10.1586/14787210.2015.101947125724113
   PubMed Web of Science ®Google Scholar
• MatsusakaK, KawakamiG, KamekawaH, et al. Pneumonia risks in bedridden patients receiving oral care and their screening tool: malnutrition and urinary tract infection-induced inflammation. Geriatr Gerontol Int. 2018;18:714–722. doi:10.1111/ggi.1323629380508
   PubMed Web of Science ®Google Scholar
• Ignacio de UlíbarriJ, González-MadroñoA, de VillarNG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20:38–45.
   PubMedGoogle Scholar
• LimJU, LeeJH, KimJS, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2465–2475. doi:10.2147/COPD.S14129528860741
   PubMed Web of Science ®Google Scholar
• VestiboJ, EdwardsLD, ScanlonPD, et al. ECLIPSE investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;465:1184–1192. doi:10.1056/NEJMoa1105482
   Web of Science ®Google Scholar
• SuzukiM, MakitaH, KonnnoS, et al. Hokkaido COPD Cohort Study Investigators. Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194:1358–1365. doi:10.1164/rccm.201602-0353OC27224255
   PubMed Web of Science ®Google Scholar
• TakahashiS, BetsuyakuT. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries. Respir Investig. 2015;53:259–270. doi:10.1016/j.resinv.2015.05.005
   PubMedGoogle Scholar
• LinJ, XuY, WuX, et al. Risk factors associated with chronic obstructive pulmonary disease early readmission. Curr Med Res Opin. 2014;30:315–320. doi:10.1185/03007995.2013.85862324156615
   PubMed Web of Science ®Google Scholar
• Global Initiative for Obstructive Lung Disease. GOLD 2019 report. Global strategy for the diagnosis, management and prevention of COPD; 2019 Report Available from: https://goldcopd.org. Accessed 41, 2020.
   Google Scholar
• ZhaoZ, JiangC, ZhaoD, et al. Two CHRN susceptibility variants for COPD are genetic determinants of emphysema and chest computed tomography manifestations in Chinese patients. Int J Chron Obstruct Pulmon Dis. 2017;12:1447–1455. doi:10.2147/COPD.S13401028553097
   PubMed Web of Science ®Google Scholar
• JacksonSS, DowlingHF, SpiesmanIG, et al. Transmission of the common cold to volunteers under controlled conditions. I. The common colds as a clinical entity. Arch Intern Med. 1958;101:267–278. doi:10.1001/archinte.1958.00260140099015
   Google Scholar
• JacksonML, NelsonJC, JacksonLA. Risk factors for community-acquired pneumonia in immunocompetent seniors. J Am Geriatr Soc. 2009;57:882–888. doi:10.1111/j.1532-5415.2009.02223.x19453307
   PubMed Web of Science ®Google Scholar
• TamadaT, SugiuraH, TakahashiT, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169–2176. doi:10.2147/COPD.S8827426491283
   PubMed Web of Science ®Google Scholar
• HarunaA, MutoS, NakanoY, et al. CT scan findings of emphysema predict mortality in COPD. Chest. 2010;138:635–640. doi:10.1378/chest.09-283620382712
   PubMed Web of Science ®Google Scholar
• LesourdBM. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr. 1997;66:478S–484S. doi:10.1093/ajcn/66.2.478S9250135
   PubMed Web of Science ®Google Scholar
• MaJH, SongSH, GuoM, et al. Long-term exposure to PM2.5 lowers influenza virus resistance via down-regulating pulmonary macrophage Kdm6a and mediates histones modification in IL-6 and IFN-β promoter regions. Biochem Biophys Res Commun. 2017;493:1122–1128. doi:10.1016/j.bbrc.2017.09.01328887033
   PubMed Web of Science ®Google Scholar
• OzawaH, AsaiS, JinG, et al. Severe pneumonia caused by a novel influenza A (H1N1) virus in an asymptomatic emphysematous smoker. Intern Med. 2010;49:1667–1670. doi:10.2169/internalmedicine.49.329320686312
   PubMed Web of Science ®Google Scholar
• SeemungalT, Harper-OwenR, BhowmikA, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1618–1623. doi:10.1164/ajrccm.164.9.210501111719299
   PubMed Web of Science ®Google Scholar
• WuZ, YangD, GeZ, et al. Body mass index of patients with chronic obstructive pulmonary disease is associated with pulmonary function and exacerbations: a retrospective real world research. J Thorac Dis. 2018;10:5086–5099. doi:10.21037/jtd.2018.08.6730233884
   PubMed Web of Science ®Google Scholar
• ZhouY, WangX, ZengX, et al. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low dose, slow-release theophylline in the treatment of COPD for 1 year. Respirology. 2006;11:603–610. doi:10.1111/j.1440-1843.2006.00897.x16916334
   PubMed Web of Science ®Google Scholar
• TatsumiK, FukuchiY, Study GroupPEACE. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2007;55:1884–1886. doi:10.1111/j.1532-5415.2007.01373.x
   PubMed Web of Science ®Google Scholar
• DaviskasE, AndersonSD, ShawJ, et al. Mucociliary clearance in patients with chronic asthma: effects of β2 agonists. Respilorogy. 2005;10:426–435.
   PubMed Web of Science ®Google Scholar
• SinghD, KolsumU, BrightlingCE, et al. ECLIPSE investigators. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44:1697–1700. doi:10.1183/09031936.0016241425323230
   PubMed Web of Science ®Google Scholar
• TuncayEA, KarakurtZ, AksoyE, et al. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Int J Chron Obstruct Pulmon Dis. 2017;12:3361–3370. doi:10.2147/COPD.S14726129200843
   PubMed Web of Science ®Google Scholar
• PeduzziP, ConcatoJ, FeinsteinAR, et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503–1510. doi:10.1016/0895-4356(95)00048-88543964
   PubMed Web of Science ®Google Scholar
• TatsumiK, KasaharaY, KurosuK, et al. Clinical phenotypes of COPD: results of a Japanese epidemiology survey. Respirology. 2004;9:331–336. doi:10.1111/j.1440-1843.2004.00611.x15363004
   PubMed Web of Science ®Google Scholar
• MiyazakiM, NakamuraH, ChubachiS, et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13. doi:10.1186/1465-9921-15-1324502760
   PubMed Web of Science ®Google Scholar